Medable
Healthcare Software · California, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
525 University Ave Ste A70, Palo Alto, C...Phone Number
(877) 820-6259Website
www.medable.comRevenue
$73.5 MillionIndustry
About Medable
Medable Org Chart
Is Medable your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Medable recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Medable had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check if Medable has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Medable has new funding data
Congratulate Masked Content for being promoted to Masked Content at Medable
Medable, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Medable launches new products
Check out if Medable is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Medable
Compare insights from companies similar to Medable, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Medable is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Medable is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Medable.
Medable financials insights
Gather financial insights about Medable, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$3.6M
Series B
$16.2M
Debt
$1M
Other Financing Round
$25M
Series C
$169M
Series D
$304M
Medable Tech Stack
A closer look at the technologies used by Medable
Most Recent Scoops
Medable News & Media
Medable Introduces Long-Term Follow-Up Model for Cell & Gene Therapy (CGT) Trials to Reduce Costs and Improve Patient Access
PALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc., a leading technology platform provider for decentralized clinical trials, today unveiled its digital-first Long-Term Follow-Up (LTFU) model for cell and gene therapy (CGT) trials. Medable’s platform reduces the burden on patients and sites involved in complex CGT trials and enhances scientific integrity with sustainable data capture across the FDA-required 15-year follow-up period for certain CGTs, including those using genome-editing techniquesMedable Releases New Digital Oncology Trial Offering to Reduce Complexity for Sites, Sponsors, Patients, and Caregivers
PALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc., a leading provider of clinical development and eCOA technology, today announced its next-generation digital oncology trial offering specifically designed to reduce operational complexity for sites and sponsors while meeting vulnerable cancer patients and their caregivers where they are with accessible, digital tools. Oncology trials have historically been complicated but are becoming increasingly complex due to factors like advanced precision meMedable Achieves Landmark CNIL Approval, Expanding Access for Digital Clinical Trials Across the European Union
PALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc., a leading provider of clinical development technology, announced that its eConsent and eCOA solutions have been approved for use in two clinical studies in eight countries outside of the European Union by France’s Commission Nationale de l’Informatique et des Libertés (CNIL). This milestone makes Medable uniquely capable of operating as a data processor outside of the CNIL MR-001 Reference Methodology requirements for a France-based clinical triCORRECTING and REPLACING New Data Reveals DCT Components Linked to Improvements in Clinical Trial Access Among Underrepresented Communities
PALO ALTO, Calif.--(BUSINESS WIRE)--Please replace the release dated Jan. 28, 2025 with the following corrected version due to multiple revisions. The updated release reads: NEW DATA REVEALS DCT COMPONENTS LINKED TO IMPROVEMENTS IN CLINICAL TRIAL ACCESS AMONG UNDERREPRESENTED COMMUNITIES Representation of Asian participants increased by six percentage points; American Indian/Alaska Native representation quadrupled; Female representation rose from 49.0% to 55.7% Medable Inc., a leading provider
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Medable
Medable is a privately held, venture-backed company headquartered in Palo Alto, California. The company is focused on building a platform for clinical trial execution, enabling patient generated data to drive clinical research, and precision and predictive medicine. The business is located in Palo Alto, California.... Read More